Ogechukwu Imonugo, DPM
Podiatrist · Columbia, MDNPI 1619330172
Payments from drug & device makers
What this record shows
16 manufacturers reported payments, led by ALON Medical Technology at 59.7% of the total. Reporting peaked in 2021 at $1,200 and has fallen 62.0% since, to $456 in 2025.
Across 35 payments — averaging $57.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ALON Medical Technology$1K
- Amgen$189
- Novo Nordisk$106
- Medtronic$96
- Nevro Corp.$69
- Paratek Pharmaceuticals, Inc.$54
- plus $297 from 10 others
What the payments were for
- Food & beverage$81040%
- Education$1,20060%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ALON Medical Technology | 1 | $1,200 |
| Amgen | 9 | $189 |
| Novo Nordisk | 1 | $106 |
| Medtronic | 2 | $96 |
| Nevro Corp. | 4 | $69 |
| Paratek Pharmaceuticals, Inc. | 3 | $54 |
| Orthofix Medical, Inc. | 3 | $46 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $43 |
| IBSA Pharma Inc. | 2 | $42 |
| Sebela Pharmaceuticals Inc. | 2 | $40 |
| Averitas Pharma Inc. | 1 | $29 |
| Bioventus LLC | 1 | $26 |
| AbbVie | 1 | $25 |
| Cashflow Solutions, LLC | 1 | $19 |
| Globus Medical | 1 | $14 |
| Biowound Solutions, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$106
How this compares
$2,010 in reported general payments places this provider in the 70th percentile of 183 podiatrist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 18 | $458 |
| Mupirocin | 24 | $213 |
| Cephalexin | 12 | $36 |
| Ibuprofen | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Columbia
- Daniel HalaykoColumbia$3K
- Ijeoma NwujuBethesda$601K
- David Linla Plata$75K
- Ira GottliebPasadena$25K
- Teresa HilliardHyattsville$19K
- Andreas KaikisHagerstown$17K
- Tiffany HohBaltimore$17K
- Shashank SrivastavaFrederick$15K
- Hayden HofflerCatonsville$15K
- Enzo LeonePasadena$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.